Equity Overview
Price & Market Data
Price: $4.82
Daily Change: +$0.12 / 2.49%
Daily Range: $4.70 - $5.00
Market Cap: $130,722,016
Daily Volume: 128,492
Performance Metrics
1 Week: -22.97%
1 Month: -7.47%
3 Months: -19.45%
6 Months: -59.58%
1 Year: -54.43%
YTD: -56.95%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.